Clinsync Clinical Research Private Limited, a active private limited company, was established on 21 March 2011 in Hyderabad, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U73200TG2011PTC073413. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹6.00 Cr and a paid-up capital of ₹4.39 Cr.
It upholds a compliant status. Employing 147 professional, Its leadership includes Suresh Kumar Nandiraju (Director), Attili Venkata Satya Suresh (Director), Koteswara Prasad Sripathipanditaradhyula (Director). Past directors included Suresh Kumar Nandiraju, Attili Venkata Satya Suresh, Chinnababu Anjaneya Sunkavalli. It holds ₹2.26 Cr open charges and ₹4.56 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Jsr Mall, Plot No. 7 To 18, Madinaguda Village Serilingampally Mandal, Hyderabad, Telangana, 500050.
U73200TG2011PTC073413
073413
21 March 2011
₹6.00 Cr
₹4.39 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Clinsync Clinical Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Kumar Nandiraju | Director | 26 Aug 2024 | Current |
| Attili Venkata Satya Suresh | Director | 30 Nov 2020 | Current |
| Koteswara Prasad Sripathipanditaradhyula | Director | 30 Nov 2020 | Current |
| Sandhya Nandiraju | Whole-Time Director | 08 Jan 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 26 Mar 2020 | Past |
| Pramod Abcsdd | Director | 05 May 2020 | Past |
| Pramod Abcsdd | Director | 20 Apr 2018 | Past |
| Pramod Abcsdd | Director | 09 Oct 2023 | Past |
| Pramod Abcsdd | Director | 20 Apr 2018 | Past |
| Pramod Abcsdd | Additional Director | 13 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Clinsync Clinical Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 18.61% decrease. The company also saw a substantial fall in profitability, with a 151.67% decrease in profit. The company's net worth observed a substantial decline by a decrease of 10.63%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Clinsync Clinical Research had a promoter holding of 24.00% and a public holding of 76.01%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,599,253.00
₹45,600,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Apr 2021 | Others | ₹2.50 M | Open |
| 10 Mar 2017 | Others | ₹1.00 Cr | Open |
| 31 Dec 2016 | Others | ₹1.01 Cr | Open |
| 25 Nov 2019 | Axis Bank Limited | ₹3.10 Cr | Satisfied |
| 12 Feb 2015 | Andhra Pradesh State Financial Corporation | ₹1.46 Cr | Satisfied |
Explore comprehensive loan charge details -
Clinsync Clinical Research has a workforce of 147 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Clinsync Clinical Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Clinsync Clinical Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Clinsync Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Suresh Kumar Nandiraju was appointed as a Director was appointed as a Director on 26 Aug 2024 & has been associated with this company since 1 year 3 months . was completed.
Progress on Clinsync Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100463380 was registered on 26 Apr 2021. was recorded as a recent event.
A charge registered on 25 Nov 2019 via Charge ID 100374185 with Axis Bank Limited was fully satisfied on 28 Jan 2021. was recorded as a recent event.
Progress on Attili Venkata Satya Suresh was appointed as a Director was appointed as a Director on 30 Nov 2020 & has been associated with this company since 4 years 11 months . was documented.
The CIN of Clinsync Clinical Research Private Limited is U73200TG2011PTC073413.
Clinsync Clinical Research Private Limited is headquartered at Jsr Mall, Plot No. 7 To 18, Madinaguda Village Serilingampally Mandal, Hyderabad, Telangana, 500050.
Clinsync Clinical Research Private Limited was incorporated on 21 March 2011.
The current directors of Clinsync Clinical Research Private Limited are
The primary industry of Clinsync Clinical Research Private Limited is Professional, Scientific And Technical.
Clinsync Clinical Research Private Limited is unlisted.
The authorized capital of Clinsync Clinical Research Private Limited is ₹6.00 Cr, and the paid-up capital is ₹4.39 Cr.
The compliance status of Clinsync Clinical Research Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX